An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Olema Pharmaceuticals, Inc. (Nasdaq: OLMA) will participate in various investor conferences in May, including the BofA Securities Health Care Conference, H.C. Wainwright BioConnect Investor Conference, UBS Spring Biotech Symposium, and TD Cowen Oncology Innovation Summit. The management team will engage in presentations, fireside chats, and one-on-one meetings to discuss the company's targeted therapies for women's cancers.
Olema Pharmaceuticals, Inc. (Nasdaq: OLMA) parteciperà a vari conferenze di investitori in maggio, incluse la Conferenza sulla Sanità di BofA Securities, la Conferenza degli Investitori BioConnect di H.C. Wainwright, il Simposio Biotech di Primavera della UBS e il Summit sull'Innovazione Oncologica di TD Cowen. Il team di gestione parteciperà a presentazioni, incontri informali e incontri individuali per discutere delle terapie mirate dell'azienda per i tumori femminili.
Olema Pharmaceuticals, Inc. (Nasdaq: OLMA) participará en varias conferencias de inversores en mayo, incluyendo la Conferencia de Salud de BofA Securities, la Conferencia BioConnect de Inversores de H.C. Wainwright, el Simposio de Biotech de Primavera de UBS y la Cumbre de Innovación en Oncología de TD Cowen. El equipo directivo realizará presentaciones, charlas informales y reuniones individuales para discutir las terapias dirigidas de la compañía para los cánceres de mujeres.
올레마 파마슈티컬스, 주식회사(Nasdaq: OLMA)가 5월에 여러 투자자 콘퍼런스에 참여할 예정입니다. 이에는 BofA 증권 헬스케어 콘퍼런스, H.C. 웨인라이트 바이오커넥트 투자자 콘퍼런스, UBS 스프링 바이오텍 심포지엄, TD 코웬 종양학 혁신 정상회의가 포함됩니다. 경영팀은 회사의 여성암을 위한 표적 치료법에 대해 논의하기 위해 발표, 간담회 및 일대일 회의에 참여할 것입니다.
Olema Pharmaceuticals, Inc. (Nasdaq: OLMA) participera à diverses conférences d'investisseurs en mai, y compris la Conférence sur les soins de santé de BofA Securities, la Conférence des investisseurs BioConnect de H.C. Wainwright, le Symposium de biotechnologie de printemps d'UBS, et le Sommet d'innovation en oncologie de TD Cowen. L'équipe de gestion participera à des présentations, des discussions informelles et des rencontres en tête-à-tête pour discuter des thérapies ciblées de l'entreprise pour les cancers féminins.
Olema Pharmaceuticals, Inc. (Nasdaq: OLMA) wird im Mai an verschiedenen Investorenkonferenzen teilnehmen, darunter die BofA Securities Health Care Konferenz, die H.C. Wainwright BioConnect Investorenkonferenz, das UBS Frühjahrs-Biotechnologie-Symposium und der TD Cowen Onkologie-Innovationsgipfel. Das Managementteam wird Präsentationen halten, an Kamingesprächen teilnehmen und Einzelgespräche führen, um die gezielten Therapien des Unternehmens für Frauenkrebs zu erörtern.
Positive
None.
Negative
None.
SAN FRANCISCO, May 01, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema”, “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers, today announced that its management team will participate in the following upcoming investor conferences:
BofA Securities Health Care Conference 2024 Date: Tuesday, May 14, 2024, at 4:35 p.m. PT Location: Encore Hotel in Las Vegas, NV Format: Presentation
H.C. Wainwright 2nd Annual BioConnect Investor Conference Date: Monday, May 20, 2024, at 4:00 p.m. ET Location: NASDAQ Headquarters in New York, NY Format: Fireside Chat
UBS Spring Biotech Symposium Date: Tuesday, May 21, 2024 Location: New York, NY Format: One-on-one Meetings
TD Cowen 5th Annual Oncology Innovation Summit Date: Tuesday, May 28, 2024, at 10:00 a.m. ET Location: Virtual Format: Fireside Chat
Live webcasts of the presentations and any accompanying materials will be available under the News & Events section of Olema’s investor relations website at ir.olema.com. The webcasts will be archived for at least 30 days.
About Olema Oncology Olema Oncology is a clinical-stage biopharmaceutical company committed to transforming the standard of care and improving outcomes for women living with cancer. Olema is advancing a pipeline of novel therapies by leveraging our deep understanding of endocrine-driven cancers, nuclear receptors, and mechanisms of acquired resistance. In addition to our lead product candidate, palazestrant (OP-1250), a proprietary, orally-available complete estrogen receptor (ER) antagonist (CERAN) and a selective ER degrader (SERD), Olema is developing a potent KAT6 inhibitor (OP-3136). Olema is headquartered in San Francisco and has operations in Cambridge, Massachusetts. For more information, please visit us at www.olema.com.
Contact: Geoffrey Mogilner, Vice President, Investor Relations and Communications ir@olema.com
FAQ
When will Olema Pharmaceuticals participate in the BofA Securities Health Care Conference?
Olema Pharmaceuticals will participate in the BofA Securities Health Care Conference on Tuesday, May 14, 2024, at 4:35 p.m. PT at the Encore Hotel in Las Vegas, NV.
Where can investors access the live webcasts of the presentations?
Investors can access the live webcasts of the presentations and any accompanying materials under the News & Events section of Olema’s investor relations website at ir.olema.com.
What type of format will the H.C. Wainwright 2nd Annual BioConnect Investor Conference feature?
The H.C. Wainwright 2nd Annual BioConnect Investor Conference will feature a Fireside Chat on Monday, May 20, 2024, at 4:00 p.m. ET at the NASDAQ Headquarters in New York, NY.
What is the focus of Olema Pharmaceuticals?
Olema Pharmaceuticals is focused on the discovery, development, and commercialization of targeted therapies for women's cancers.
What is the stock symbol of Olema Pharmaceuticals?
The stock symbol of Olema Pharmaceuticals is OLMA on the Nasdaq.
olema oncology is a biopharmaceutical company developing innovative targeted therapies for women’s cancers. our lead program, op-1250, a potential best-in-class complete estrogen receptor antagonist (ceran), is in development to treat estrogen receptor-positive (er+), human epidermal growth factor receptor 2-negative (her2-) breast cancer. olema recently initiated a phase 1/2 dose-escalation and expansion clinical trial of op-1250. we are supported in our mission by experienced and accomplished scientists and board members, leading healthcare investors and some of the most innovative pharma companies. for more information about the company please visit www.olema.com.
